retatrutide liver benefits (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works retatrutide for diabetes type 2

Ive talked about the upsides of pharmacologically boosting GLP-1 activity in terms of weight loss, given the ravages of obesity, and Ive also discussed its downsides, including common gastrointestinal reactions and muscle loss, as well as the rarer or more speculative side effects such as thyroid cancer, pancreatitis, and pancreatic cancer

Medical providers at virtual care companies that provide weight loss medications, both branded medications and compounded versions, say patients still face challenges accessing the branded drugs

Producers and important dietary sources of ochratoxin A and citrinin

Anesthetic agents interact indirectly through aspiration risk

Jrgensen JO, Krag M, Jessen N, Norrelund H, Vestergaard ET, Moller N, et al